EFTA Document EFTA01452943

4 February 2014 Health Care Facilities and Services HCA Holdings, Inc. (Figure 6: Balance sheet & Cash flow analysis IS in MM, except per share data) Sias Wane GAM= Marls ♦MY% ani.S1•0 ebl 1 1 All 160 SOO Oa MO Oa Ha wla 4411 rs a•Marlia •ORk Oa: .ariciaa m 11.11 I teal ^Ma *mflaiiiiia it] 11}11 no VII ililaeasalidagiallaiseltala p.. —Stre rwr Ewa %maim :Oa inatai• imasitraasoni aiaka d I Iw ni41 %Mann Mt :ar.eamania dl.r. 4n/ !Val 410 tart Caitenialnialrilaisaalary4 KW) R$4 ata, asaaataijaial I05 ala 0•1•0•0441011C Cuadiria114040 Mil afil ,4•0:41antetrat 401.4.01 • • it • 44, al 401 NM 417 Ilpll 041i MN LX till Ma • 6n nig 01 :1 IWO 1.4/9 0401 MAY I IV 4194 424 0.164i I t, 1517 PMN Sn 14, on MO MS. SIX. M, I./41 tl U 0.17b 131% Oa) 40% In ila In la% lit! 00% Ca4I O.14C1 IN, a* IC1 fin I401 11.011 Sal Na 11,11 SY) 1101 176 414* ...a> NI1 940194 002 1706 115 Mai 120.-41 MASI VIM SRNS 44. 41i •P 4te ASS MS 411 440 446 (00 40% wa• I PSI) MC) OW) ((MU Na 144% en sr% ITH aR PO MN I1.7), SS: IN SW MO Ie.»? Via 1•12 MI MN 0414 WWI 171,16 IVACO I2).1V 1>19p 4$• 4 41.• Is 41) 412 401 al MO Savor DaIld* dint OMWS/teot. Guidance. HCA issued 2014 guidance as follows: revenue $35.50436.50 billion, adjusted EBITDA $6.60-$6.85 billion, adjusted EPS $3.4543.75, capex approx. $2.2 billion. 2014 guidance includes a benefit to adjusted EBITDA from PPACA of approx. 1%-2%, which implies $65-$135 million benefit. HCA expects 2013 adj. admits to range from +1% to +2% and rev/ adj. admits +2% to+3%. Guidance also includes HITECH incentive payments $110-$130 million and HITECH related expenses of $110-$130 million. We believe guidance was very conservatively established, but not unexpected. EBITDA guidance represents growth of flat to +4% and relative to consensus EBTIDA of $6.82 billion we believe HCA's outlook provides a reasonable start. Recall HCA finished 2013 with EBITDA -1% above the top-end of its original guidance range. F gum 7 F€CA 2014 Guidance vs. DBe and Consensus 2014 Guidance DB Estimate Consensus Resenues $35.508 - $36.508 $36.5868 536.1388 Adjusted EBITDA 56.606 • 56.8513 $7.0498 S6 8218 PPACA Benet' $66M - $137M $15014 - $20001 NA Adjusted EPS $3.45 - $3.75 $3.92 $3.78 Capex Approx. $2.2B $2.2B $2.05 •HCA guidance br 2014 PPACA benefit approx. 1% - 2% of adjusted EIMTDA 501./a7044/00M Sint SaVenVni9Oni Mama, /haws Deutsche Bank Securities Inc. Pago 7 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0110278 SDNY_GM_00256462 EFTA01452943